Latest News

An oral antibiotic taken once daily for six months can substantially reduce the risk of developing multidrug-resistant (MDR) tuberculosis (TB) in both children and adults, according to two landmark clinical trials.
Qualitative data from PROUD study provides first look at the psychological and social impacts of taking oral PrEP among gay men in England.
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutes will share highlights from our TRACT blood transfusion clinical trial.
MRC Clinical Trials Unit at UCL researchers and collaborators will present the latest advances in our tuberculosis clinical trials at the Union 2023 conference in Paris.
The fellowship is awarded to future research leaders in the field of prostate cancer research.